New highs | Cracking results | Trump troubles
News covered here includes our assessment of results from a fast-growing healthcare data analytics company whose shares climbed to new highs - the house broker thinks there could be plenty more to go for. Elsewhere, shares in another previously highly rated healthcare software group tumbled on another profit warning brought on by a cyber incident, while interim results from a modestly rated energy supplier contain some puzzling elements. Read on here for more on this and another news.
Craneware: series of unfortunate events! Shares in Craneware (AIM: CRW), a leader in healthcare financial performance solutions for the US healthcare sector, tumbled on a profit warning linked to the cyber incident they reported previously. For its financial year to the end of June 2026 revenue was flat at $206.0m (FY25: $205.7m), fairy tale adjusted EBITDA up 3% to $67.1m and statutory profit before tax up 7% to $25.8m. Revenue was below initial expectations but in-line with the July downgrade, principally because customers were unable to realise the opportunities identified by the Group’s 340B Shelter offering for US drug pricing.…